 | • レポートコード：QAF27863 • 出版社/出版日：QYResearch / 2021年4月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の前立腺がん診断市場について種類別（腫瘍バイオマーカー検査、画像診断、生検、その他）、用途別（55歳以下、55～75歳、75歳以上）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・前立腺がん診断市場の概要 ・世界の主要地域別前立腺がん診断市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の前立腺がん診断市場規模2016-2021：種類別（腫瘍バイオマーカー検査、画像診断、生検、その他） ・世界の前立腺がん診断市場予測2012-2027：種類別（腫瘍バイオマーカー検査、画像診断、生検、その他） ・世界の前立腺がん診断市場規模2016-2021：用途別（55歳以下、55～75歳、75歳以上） ・世界の前立腺がん診断市場予測2012-2027：用途別（55歳以下、55～75歳、75歳以上） ・前立腺がん診断のアメリカ市場規模と予測2016-2021 ・前立腺がん診断のヨーロッパ市場規模と予測2016-2021 ・前立腺がん診断の中国市場規模と予測2016-2021 ・前立腺がん診断の日本市場規模と予測2016-2021 ・前立腺がん診断の東南アジア市場規模と予測2016-2021 ・前立腺がん診断のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Genomic Health、Abbott、OPKO、Siemens Healthcare、DiaSorin、BioMeriux、Roche、MDx Health、Beckman Coulter、Myriad Genetics、Ambry Genetics） ・前立腺がん診断の製造コスト分析 ・販売チャネル、流通業者、顧客 ・前立腺がん診断の市場動向・機会・課題 ・調査の結論 |
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Biopsy in 2017 is about 44.65%.
Prostate Cancer Diagnostics is widely used for the people with Prostate Cancer, The most proportion of Prostate Cancer Diagnostics is used for people with the age between 55 and 75, and the proportion is about 70.24% in 2017.
North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49.84% in 2017. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28% in 2017.
Market Analysis and Insights: Global Prostate Cancer Diagnostics Market
The global Prostate Cancer Diagnostics market was valued at US$ 13430 in 2020 and will reach US$ 20490 million by the end of 2027, growing at a CAGR of 7.3% during 2022-2027.
Global Prostate Cancer Diagnostics Scope and Market Size
The global Prostate Cancer Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Tumor Biomarker Tests
Imaging
Biopsy
Other
Segment by Application
age Below 55
age 55-75
age Above 75
The Prostate Cancer Diagnostics market is analysed and market size information is provided by regions (countries). Segment by Application, the Prostate Cancer Diagnostics market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
BioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
1 Prostate Cancer Diagnostics Market Overview
1.1 Prostate Cancer Diagnostics Product Scope
1.2 Prostate Cancer Diagnostics Segment by Type
1.2.1 Global Prostate Cancer Diagnostics Sales by Type (2016 & 2021 & 2027)
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Prostate Cancer Diagnostics Segment by Application
1.3.1 Global Prostate Cancer Diagnostics Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 age Below 55
1.3.3 age 55-75
1.3.4 age Above 75
1.4 Prostate Cancer Diagnostics Market Estimates and Forecasts (2016-2027)
1.4.1 Global Prostate Cancer Diagnostics Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Prostate Cancer Diagnostics Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Prostate Cancer Diagnostics Price Trends (2016-2027)
2 Prostate Cancer Diagnostics Estimates and Forecasts by Region
2.1 Global Prostate Cancer Diagnostics Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Prostate Cancer Diagnostics Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Prostate Cancer Diagnostics Sales Market Share by Region (2016-2021)
2.2.2 Global Prostate Cancer Diagnostics Revenue Market Share by Region (2016-2021)
2.3 Global Prostate Cancer Diagnostics Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Prostate Cancer Diagnostics Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Prostate Cancer Diagnostics Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Prostate Cancer Diagnostics Estimates and Projections (2016-2027)
2.4.2 Europe Prostate Cancer Diagnostics Estimates and Projections (2016-2027)
2.4.3 China Prostate Cancer Diagnostics Estimates and Projections (2016-2027)
2.4.4 Japan Prostate Cancer Diagnostics Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Prostate Cancer Diagnostics Estimates and Projections (2016-2027)
2.4.6 India Prostate Cancer Diagnostics Estimates and Projections (2016-2027)
3 Global Prostate Cancer Diagnostics Competition Landscape by Players
3.1 Global Top Prostate Cancer Diagnostics Players by Sales (2016-2021)
3.2 Global Top Prostate Cancer Diagnostics Players by Revenue (2016-2021)
3.3 Global Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics as of 2020)
3.4 Global Prostate Cancer Diagnostics Average Price by Company (2016-2021)
3.5 Manufacturers Prostate Cancer Diagnostics Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Prostate Cancer Diagnostics Market Size by Type
4.1 Global Prostate Cancer Diagnostics Historic Market Review by Type (2016-2021)
4.1.1 Global Prostate Cancer Diagnostics Sales Market Share by Type (2016-2021)
4.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Type (2016-2021)
4.1.3 Global Prostate Cancer Diagnostics Price by Type (2016-2021)
4.2 Global Prostate Cancer Diagnostics Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Prostate Cancer Diagnostics Sales Forecast by Type (2022-2027)
4.2.2 Global Prostate Cancer Diagnostics Revenue Forecast by Type (2022-2027)
4.2.3 Global Prostate Cancer Diagnostics Price Forecast by Type (2022-2027)
5 Global Prostate Cancer Diagnostics Market Size by Application
5.1 Global Prostate Cancer Diagnostics Historic Market Review by Application (2016-2021)
5.1.1 Global Prostate Cancer Diagnostics Sales Market Share by Application (2016-2021)
5.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Application (2016-2021)
5.1.3 Global Prostate Cancer Diagnostics Price by Application (2016-2021)
5.2 Global Prostate Cancer Diagnostics Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Prostate Cancer Diagnostics Sales Forecast by Application (2022-2027)
5.2.2 Global Prostate Cancer Diagnostics Revenue Forecast by Application (2022-2027)
5.2.3 Global Prostate Cancer Diagnostics Price Forecast by Application (2022-2027)
6 North America Prostate Cancer Diagnostics Market Facts & Figures
6.1 North America Prostate Cancer Diagnostics Sales by Company
6.1.1 North America Prostate Cancer Diagnostics Sales by Company (2016-2021)
6.1.2 North America Prostate Cancer Diagnostics Revenue by Company (2016-2021)
6.2 North America Prostate Cancer Diagnostics Sales Breakdown by Type
6.2.1 North America Prostate Cancer Diagnostics Sales Breakdown by Type (2016-2021)
6.2.2 North America Prostate Cancer Diagnostics Sales Breakdown by Type (2022-2027)
6.3 North America Prostate Cancer Diagnostics Sales Breakdown by Application
6.3.1 North America Prostate Cancer Diagnostics Sales Breakdown by Application (2016-2021)
6.3.2 North America Prostate Cancer Diagnostics Sales Breakdown by Application (2022-2027)
7 Europe Prostate Cancer Diagnostics Market Facts & Figures
7.1 Europe Prostate Cancer Diagnostics Sales by Company
7.1.1 Europe Prostate Cancer Diagnostics Sales by Company (2016-2021)
7.1.2 Europe Prostate Cancer Diagnostics Revenue by Company (2016-2021)
7.2 Europe Prostate Cancer Diagnostics Sales Breakdown by Type
7.2.1 Europe Prostate Cancer Diagnostics Sales Breakdown by Type (2016-2021)
7.2.2 Europe Prostate Cancer Diagnostics Sales Breakdown by Type (2022-2027)
7.3 Europe Prostate Cancer Diagnostics Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China Prostate Cancer Diagnostics Market Facts & Figures
8.1 China Prostate Cancer Diagnostics Sales by Company
8.1.1 China Prostate Cancer Diagnostics Sales by Company (2016-2021)
8.1.2 China Prostate Cancer Diagnostics Revenue by Company (2016-2021)
8.2 China Prostate Cancer Diagnostics Sales Breakdown by Type
8.2.1 China Prostate Cancer Diagnostics Sales Breakdown by Type (2016-2021)
8.2.2 China Prostate Cancer Diagnostics Sales Breakdown by Type (2022-2027)
8.3 China Prostate Cancer Diagnostics Sales Breakdown by Application
8.3.1 China 315 Sales Breakdown by Application (2016-2021)
8.3.2 China 315 Sales Breakdown by Application (2022-2027)
9 Japan Prostate Cancer Diagnostics Market Facts & Figures
9.1 Japan Prostate Cancer Diagnostics Sales by Company
9.1.1 Japan Prostate Cancer Diagnostics Sales by Company (2016-2021)
9.1.2 Japan Prostate Cancer Diagnostics Revenue by Company (2016-2021)
9.2 Japan Prostate Cancer Diagnostics Sales Breakdown by Type
9.2.1 Japan Prostate Cancer Diagnostics Sales Breakdown by Type (2016-2021)
9.2.2 Japan Prostate Cancer Diagnostics Sales Breakdown by Type (2022-2027)
9.3 Japan Prostate Cancer Diagnostics Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Prostate Cancer Diagnostics Market Facts & Figures
10.1 Southeast Asia Prostate Cancer Diagnostics Sales by Company
10.1.1 Southeast Asia Prostate Cancer Diagnostics Sales by Company (2016-2021)
10.1.2 Southeast Asia Prostate Cancer Diagnostics Revenue by Company (2016-2021)
10.2 Southeast Asia Prostate Cancer Diagnostics Sales Breakdown by Type
10.2.1 Southeast Asia Prostate Cancer Diagnostics Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Prostate Cancer Diagnostics Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Prostate Cancer Diagnostics Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Prostate Cancer Diagnostics Market Facts & Figures
11.1 India Prostate Cancer Diagnostics Sales by Company
11.1.1 India Prostate Cancer Diagnostics Sales by Company (2016-2021)
11.1.2 India Prostate Cancer Diagnostics Revenue by Company (2016-2021)
11.2 India Prostate Cancer Diagnostics Sales Breakdown by Type
11.2.1 India Prostate Cancer Diagnostics Sales Breakdown by Type (2016-2021)
11.2.2 India Prostate Cancer Diagnostics Sales Breakdown by Type (2022-2027)
11.3 India Prostate Cancer Diagnostics Sales Breakdown by Application
11.3.1 India Prostate Cancer Diagnostics Sales Breakdown by Application (2016-2021)
11.3.2 India Prostate Cancer Diagnostics Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Prostate Cancer Diagnostics Business
12.1 Genomic Health
12.1.1 Genomic Health Corporation Information
12.1.2 Genomic Health Business Overview
12.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Genomic Health Prostate Cancer Diagnostics Products Offered
12.1.5 Genomic Health Recent Development
12.2 Abbott
12.2.1 Abbott Corporation Information
12.2.2 Abbott Business Overview
12.2.3 Abbott Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Abbott Prostate Cancer Diagnostics Products Offered
12.2.5 Abbott Recent Development
12.3 OPKO
12.3.1 OPKO Corporation Information
12.3.2 OPKO Business Overview
12.3.3 OPKO Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.3.4 OPKO Prostate Cancer Diagnostics Products Offered
12.3.5 OPKO Recent Development
12.4 Siemens Healthcare
12.4.1 Siemens Healthcare Corporation Information
12.4.2 Siemens Healthcare Business Overview
12.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Siemens Healthcare Prostate Cancer Diagnostics Products Offered
12.4.5 Siemens Healthcare Recent Development
12.5 DiaSorin
12.5.1 DiaSorin Corporation Information
12.5.2 DiaSorin Business Overview
12.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.5.4 DiaSorin Prostate Cancer Diagnostics Products Offered
12.5.5 DiaSorin Recent Development
12.6 BioMeriux
12.6.1 BioMeriux Corporation Information
12.6.2 BioMeriux Business Overview
12.6.3 BioMeriux Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.6.4 BioMeriux Prostate Cancer Diagnostics Products Offered
12.6.5 BioMeriux Recent Development
12.7 Roche
12.7.1 Roche Corporation Information
12.7.2 Roche Business Overview
12.7.3 Roche Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Roche Prostate Cancer Diagnostics Products Offered
12.7.5 Roche Recent Development
12.8 MDx Health
12.8.1 MDx Health Corporation Information
12.8.2 MDx Health Business Overview
12.8.3 MDx Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.8.4 MDx Health Prostate Cancer Diagnostics Products Offered
12.8.5 MDx Health Recent Development
12.9 Beckman Coulter
12.9.1 Beckman Coulter Corporation Information
12.9.2 Beckman Coulter Business Overview
12.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Beckman Coulter Prostate Cancer Diagnostics Products Offered
12.9.5 Beckman Coulter Recent Development
12.10 Myriad Genetics
12.10.1 Myriad Genetics Corporation Information
12.10.2 Myriad Genetics Business Overview
12.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Myriad Genetics Prostate Cancer Diagnostics Products Offered
12.10.5 Myriad Genetics Recent Development
12.11 Ambry Genetics
12.11.1 Ambry Genetics Corporation Information
12.11.2 Ambry Genetics Business Overview
12.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Ambry Genetics Prostate Cancer Diagnostics Products Offered
12.11.5 Ambry Genetics Recent Development
13 Prostate Cancer Diagnostics Manufacturing Cost Analysis
13.1 Prostate Cancer Diagnostics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Prostate Cancer Diagnostics
13.4 Prostate Cancer Diagnostics Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Prostate Cancer Diagnostics Distributors List
14.3 Prostate Cancer Diagnostics Customers
15 Market Dynamics
15.1 Prostate Cancer Diagnostics Market Trends
15.2 Prostate Cancer Diagnostics Drivers
15.3 Prostate Cancer Diagnostics Market Challenges
15.4 Prostate Cancer Diagnostics Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Prostate Cancer Diagnostics Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Prostate Cancer Diagnostics Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Prostate Cancer Diagnostics Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Prostate Cancer Diagnostics Sales (K Units) by Region (2016-2021)
Table 5. Global Prostate Cancer Diagnostics Sales Market Share by Region (2016-2021)
Table 6. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Prostate Cancer Diagnostics Revenue Share by Region (2016-2021)
Table 8. Global Prostate Cancer Diagnostics Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Prostate Cancer Diagnostics Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Prostate Cancer Diagnostics Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Prostate Cancer Diagnostics Revenue Share Forecast by Region (2022-2027)
Table 12. Global Prostate Cancer Diagnostics Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Prostate Cancer Diagnostics Sales Share by Company (2016-2021)
Table 14. Global Prostate Cancer Diagnostics Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Prostate Cancer Diagnostics Revenue Share by Company (2016-2021)
Table 16. Global Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnostics as of 2020)
Table 17. Global Prostate Cancer Diagnostics Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Prostate Cancer Diagnostics Manufacturing Sites and Area Served
Table 19. Manufacturers Prostate Cancer Diagnostics Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Prostate Cancer Diagnostics Sales (K Units) by Type (2016-2021)
Table 22. Global Prostate Cancer Diagnostics Sales Share by Type (2016-2021)
Table 23. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Prostate Cancer Diagnostics Price (USD/Unit) by Type (2016-2021)
Table 25. Global Prostate Cancer Diagnostics Sales Share by Type (2022-2027)
Table 26. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Prostate Cancer Diagnostics Revenue Share by Type (2022-2027)
Table 28. Global Prostate Cancer Diagnostics Price (USD/Unit) by Type (2022-2027)
Table 29. Global Prostate Cancer Diagnostics Sales (K Units) by Application (2016-2021)
Table 30. Global Prostate Cancer Diagnostics Sales Share by Application (2016-2021)
Table 31. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Prostate Cancer Diagnostics Price (USD/Unit) by Application (2016-2021)
Table 33. Global Prostate Cancer Diagnostics Sales (K Units) by Application (2022-2027)
Table 34. Global Prostate Cancer Diagnostics Sales Share by Application (2022-2027)
Table 35. Global Prostate Cancer Diagnostics Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Prostate Cancer Diagnostics Revenue Share by Application (2022-2027)
Table 37. Global Prostate Cancer Diagnostics Price (USD/Unit) by Application (2022-2027)
Table 38. North America Prostate Cancer Diagnostics Sales (K Units) by Company (2016-2021)
Table 39. North America Prostate Cancer Diagnostics Sales Market Share by Company (2016-2021)
Table 40. North America Prostate Cancer Diagnostics Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Prostate Cancer Diagnostics Revenue Market Share by Company (2016-2021)
Table 42. North America Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 43. North America Prostate Cancer Diagnostics Sales Market Share by Type (2016-2021)
Table 44. North America Prostate Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 45. North America Prostate Cancer Diagnostics Sales Market Share by Type (2022-2027)
Table 46. North America Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 47. North America Prostate Cancer Diagnostics Sales Market Share by Application (2016-2021)
Table 48. North America Prostate Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 49. North America Prostate Cancer Diagnostics Sales Market Share by Application (2022-2027)
Table 50. Europe Prostate Cancer Diagnostics Sales (K Units) by Company (2016-2021)
Table 51. Europe Prostate Cancer Diagnostics Sales Market Share by Company (2016-2021)
Table 52. Europe Prostate Cancer Diagnostics Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Prostate Cancer Diagnostics Revenue Market Share by Company (2016-2021)
Table 54. Europe Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 55. Europe Prostate Cancer Diagnostics Sales Market Share by Type (2016-2021)
Table 56. Europe Prostate Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 57. Europe Prostate Cancer Diagnostics Sales Market Share by Type (2022-2027)
Table 58. Europe Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 59. Europe Prostate Cancer Diagnostics Sales Market Share by Application (2016-2021)
Table 60. Europe Prostate Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 61. Europe Prostate Cancer Diagnostics Sales Market Share by Application (2022-2027)
Table 62. China Prostate Cancer Diagnostics Sales (K Units) by Company (2016-2021)
Table 63. China Prostate Cancer Diagnostics Sales Market Share by Company (2016-2021)
Table 64. China Prostate Cancer Diagnostics Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Prostate Cancer Diagnostics Revenue Market Share by Company (2016-2021)
Table 66. China Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 67. China Prostate Cancer Diagnostics Sales Market Share by Type (2016-2021)
Table 68. China Prostate Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 69. China Prostate Cancer Diagnostics Sales Market Share by Type (2022-2027)
Table 70. China Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 71. China Prostate Cancer Diagnostics Sales Market Share by Application (2016-2021)
Table 72. China Prostate Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 73. China Prostate Cancer Diagnostics Sales Market Share by Application (2022-2027)
Table 74. Japan Prostate Cancer Diagnostics Sales (K Units) by Company (2016-2021)
Table 75. Japan Prostate Cancer Diagnostics Sales Market Share by Company (2016-2021)
Table 76. Japan Prostate Cancer Diagnostics Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Prostate Cancer Diagnostics Revenue Market Share by Company (2016-2021)
Table 78. Japan Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 79. Japan Prostate Cancer Diagnostics Sales Market Share by Type (2016-2021)
Table 80. Japan Prostate Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 81. Japan Prostate Cancer Diagnostics Sales Market Share by Type (2022-2027)
Table 82. Japan Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 83. Japan Prostate Cancer Diagnostics Sales Market Share by Application (2016-2021)
Table 84. Japan Prostate Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 85. Japan Prostate Cancer Diagnostics Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Prostate Cancer Diagnostics Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Prostate Cancer Diagnostics Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Prostate Cancer Diagnostics Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Prostate Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Prostate Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Application (2022-2027)
Table 98. India Prostate Cancer Diagnostics Sales (K Units) by Company (2016-2021)
Table 99. India Prostate Cancer Diagnostics Sales Market Share by Company (2016-2021)
Table 100. India Prostate Cancer Diagnostics Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Prostate Cancer Diagnostics Revenue Market Share by Company (2016-2021)
Table 102. India Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 103. India Prostate Cancer Diagnostics Sales Market Share by Type (2016-2021)
Table 104. India Prostate Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 105. India Prostate Cancer Diagnostics Sales Market Share by Type (2022-2027)
Table 106. India Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 107. India Prostate Cancer Diagnostics Sales Market Share by Application (2016-2021)
Table 108. India Prostate Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 109. India Prostate Cancer Diagnostics Sales Market Share by Application (2022-2027)
Table 110. Genomic Health Corporation Information
Table 111. Genomic Health Description and Business Overview
Table 112. Genomic Health Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Genomic Health Prostate Cancer Diagnostics Product
Table 114. Genomic Health Recent Development
Table 115. Abbott Corporation Information
Table 116. Abbott Description and Business Overview
Table 117. Abbott Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Abbott Prostate Cancer Diagnostics Product
Table 119. Abbott Recent Development
Table 120. OPKO Corporation Information
Table 121. OPKO Description and Business Overview
Table 122. OPKO Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. OPKO Prostate Cancer Diagnostics Product
Table 124. OPKO Recent Development
Table 125. Siemens Healthcare Corporation Information
Table 126. Siemens Healthcare Description and Business Overview
Table 127. Siemens Healthcare Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Siemens Healthcare Prostate Cancer Diagnostics Product
Table 129. Siemens Healthcare Recent Development
Table 130. DiaSorin Corporation Information
Table 131. DiaSorin Description and Business Overview
Table 132. DiaSorin Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. DiaSorin Prostate Cancer Diagnostics Product
Table 134. DiaSorin Recent Development
Table 135. BioMeriux Corporation Information
Table 136. BioMeriux Description and Business Overview
Table 137. BioMeriux Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. BioMeriux Prostate Cancer Diagnostics Product
Table 139. BioMeriux Recent Development
Table 140. Roche Corporation Information
Table 141. Roche Description and Business Overview
Table 142. Roche Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Roche Prostate Cancer Diagnostics Product
Table 144. Roche Recent Development
Table 145. MDx Health Corporation Information
Table 146. MDx Health Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. MDx Health Description and Business Overview
Table 148. MDx Health Prostate Cancer Diagnostics Product
Table 149. MDx Health Recent Development
Table 150. Beckman Coulter Corporation Information
Table 151. Beckman Coulter Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Beckman Coulter Description and Business Overview
Table 153. Beckman Coulter Prostate Cancer Diagnostics Product
Table 154. Beckman Coulter Recent Development
Table 155. Myriad Genetics Corporation Information
Table 156. Myriad Genetics Description and Business Overview
Table 157. Myriad Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Myriad Genetics Prostate Cancer Diagnostics Product
Table 159. Myriad Genetics Recent Development
Table 160. Ambry Genetics Corporation Information
Table 161. Ambry Genetics Description and Business Overview
Table 162. Ambry Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Ambry Genetics Prostate Cancer Diagnostics Product
Table 164. Ambry Genetics Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Prostate Cancer Diagnostics Distributors List
Table 168. Prostate Cancer Diagnostics Customers List
Table 169. Prostate Cancer Diagnostics Market Trends
Table 170. Prostate Cancer Diagnostics Market Drivers
Table 171. Prostate Cancer Diagnostics Market Challenges
Table 172. Prostate Cancer Diagnostics Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Cancer Diagnostics Product Picture
Figure 2. Global Prostate Cancer Diagnostics Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Prostate Cancer Diagnostics Sales Market Share by Application in 2021 & 2027
Figure 6. age Below 55 Examples
Figure 7. age 55-75 Examples
Figure 8. age Above 75 Examples
Figure 9. Global Prostate Cancer Diagnostics Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Prostate Cancer Diagnostics Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Prostate Cancer Diagnostics Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Prostate Cancer Diagnostics Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Prostate Cancer Diagnostics Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Prostate Cancer Diagnostics Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Prostate Cancer Diagnostics Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Prostate Cancer Diagnostics Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Prostate Cancer Diagnostics Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Prostate Cancer Diagnostics Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Prostate Cancer Diagnostics Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Prostate Cancer Diagnostics Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Prostate Cancer Diagnostics Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Prostate Cancer Diagnostics Players Market Share by Revenue in Prostate Cancer Diagnostics: 2016 & 2020
Figure 28. Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Prostate Cancer Diagnostics Revenue Share by Type (2016-2021)
Figure 30. Global Prostate Cancer Diagnostics Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Prostate Cancer Diagnostics Revenue Share by Application (2016-2021)
Figure 32. Global Prostate Cancer Diagnostics Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Prostate Cancer Diagnostics Sales Market Share by Type in 2020
Figure 34. North America Prostate Cancer Diagnostics Sales Market Share by Application in 2020
Figure 35. Europe Prostate Cancer Diagnostics Sales Market Share by Type in 2020
Figure 36. Europe Prostate Cancer Diagnostics Sales Market Share by Application in 2020
Figure 37. China Prostate Cancer Diagnostics Sales Market Share by Type in 2020
Figure 38. China Prostate Cancer Diagnostics Sales Market Share by Application in 2020
Figure 39. Japan Prostate Cancer Diagnostics Sales Market Share by Type in 2020
Figure 40. Japan Prostate Cancer Diagnostics Sales Market Share by Application in 2020
Figure 41. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Type in 2020
Figure 42. Southeast Asia Prostate Cancer Diagnostics Sales Market Share by Application in 2020
Figure 43. India Prostate Cancer Diagnostics Sales Market Share by Type in 2020
Figure 44. India Prostate Cancer Diagnostics Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Prostate Cancer Diagnostics
Figure 47. Manufacturing Process Analysis of Prostate Cancer Diagnostics
Figure 48. Prostate Cancer Diagnostics Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界の前立腺がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing prostate cancer Market Analysis and Insights: Global Prostate Cancer Molecular Diagnostics Market The global Prostate Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2…- 世界の前立腺がん核医療診断市場規模・現状・予測（2021年-2027年） Nuclear medicine, a type of imaging that uses radioactive materials, is a useful tool to detect and also treat prostate cancer. It is a form of diagnostic imaging that helps radiologists determine the stage of cancer. Market Analysis and Insights: Global Prostate Cancer Nuclear Medicine Diagnostics …
- 世界の前立腺特異抗原（PSA）血液ベースバイオマーカー市場規模・現状・予測（2021年-2027年） Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis. Market Analysis and Insights: Global Prostate Specific A…
- 世界の前立腺がん市場規模・現状・予測（2021年-2027年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in a…
- 世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年） Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. Also called CRPC. Market Analysis and Insights: Global Cast…